Rafael de Oliveira

Rafael de Oliveira

Auto-generated profile, based on publicly available information

Rafael de Oliveira

Universidade Federal da Paraíba, Brasil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
HNHermes Diniz Neto
Hermes Diniz Neto
SSS. L. Silva
S. L. Silva
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
DSDaniele Silva
Daniele Silva
ROR. F. Oliveira
R. F. Oliveira
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
In the current context of emerging drug-resistant fungal pathogens such as Candida albicans and Candida parapsilosis, discovery of new antifungal agents is an urgent matter. This research aimed to evaluate the antifungal potential of 2-chloro-N-phenylacetamide against fluconazole-resistant clinical strains of C. albicans and C. parapsilosis. The antifungal activity of 2-chloro-N-phenylacetamide was evaluated in vitro by the determination of the minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), inhibition of biofilm formation and its rupture, sorbitol and ergosterol assays, and association between this molecule and common antifungal drugs, amphotericin B and fluconazole. The test product inhibited all strains of C. albicans and C. parapsilosis, with a MIC ranging from 128 to 256 µg.mL-1, and a MFC of 512-1,024 µg.mL-1. It also inhibited up to 92% of biofilm formation and rupture of up to 87% of preformed biofilm. 2-chloro-N-phenylacetamide did not promote antifungal activity through binding to cellular membrane ergosterol nor it damages the fungal cell wall. Antagonism was observed when combining this substance with amphotericin B and fluconazole. The substance exhibited significant antifungal activity by inhibiting both planktonic cells and biofilm of fluconazole-resistant strains. Its combination with other antifungals should be avoided and its mechanism of action remains to be established.

1 January 2021 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
MHMin-Fu Huang
Min-Fu Huang
JLJosé Alixandre Sousa Luis
José Alixandre Sousa Luis
ASAlison da Silva
Alison da Silva
JRJuliana Rocha
Juliana Rocha
TLTatjana Lima
Tatjana Lima
JFJose Maria Barbosa Filho
Jose Maria Barbosa Filho
This study describes a virtual screening performed for two series of selenides (28 compounds), derived from N-phenylacetamides chlorides and 7-chloro-quinoline, to determine their potential for leishmanicidal activity against Leishmania amazonensis and Leishmania donovani. Seven compounds were predicted as potential leishmanicides; therefore, they were synthesized from elemental selenium, as a precursor for the production of NaHSe, and subsequent reactions with 4,7-dichloro-quinoline and N-phenylacetamides chlorides were performed. The compounds were characterized by infrared (IR), 1H and 13C nuclear magnetic resonance (NMR), and sent for in vitro cytotoxicity tests against L. amazonensis and were found to be active and selective, and two compounds presented half-maximal inhibitory concentrations (IC50) of 5.67 and 10.81 µg mL-1. They also presented good interaction energies in the docking study, suggesting that may exert their effects by inhibiting the N-myristoyltransferase and O-acetylserine sulfhydrylase enzymes in parasites.

1 January 2021 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
JJJoselito Souza Jr.
Joselito Souza Jr.
EMEvandro Martins
Evandro Martins
HSHelivaldo Souza
Helivaldo Souza
RORafael de Oliveira
Rafael de Oliveira
FAFrancinara Alves
Francinara Alves
JFJose Maria Barbosa Filho
Jose Maria Barbosa Filho

1 January 2020 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
RORafael de Oliveira
Rafael de Oliveira
HSHelivaldo Souza
Helivaldo Souza
FAFrancinara Alves
Francinara Alves
ASAbraão de Sousa
Abraão de Sousa
PLPriscila de Lima
Priscila de Lima
PAPetrônio de Athayde‑Filho
Petrônio de Athayde‑Filho

1 January 2023 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
HSHelivaldo Souza
Helivaldo Souza
Aleson Pereira de SousaAleson Pereira de Sousa
Aleson Pereira de Sousa
FJFrancisco Patricio De Andrade Júnior
Francisco Patricio De Andrade Júnior
PFPedro T.R. DE Figueiredo
Pedro T.R. DE Figueiredo
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Klebsiella pneumoniae is a species of Gram-negative bacteria related to a wide range of infections and high rates of drug resistance. The combined use of antibacterial agents is one of the strategies that has been analyzed in recent years as part of the alternatives in the treatment of drug-resistant infections. Recently, the antibacterial activity of of 2-chloro-N-(4-fluoro-3-nitrophenyl)acetamide has been demonstrated against K. pneumoniae, also indicating that this acetamide did not show significant cytotoxic potential in preliminary tests. Thus, it becomes an interesting substance for future studies that explore its antimicrobial capacity, including investigating its association with antibacterial drugs. Based on this, this research aimed to analyze the effects of the association of 2-chloro-N-(4-fluoro-3-nitrophenyl)acetamide (CFA) with ciprofloxacin, cefepime, ceftazidime, meropenem and imipenem against K. pneumoniae strains. The results showed additivity when the substance was combined with ciprofloxacin and cefepime, indifference when associated with ceftazidime and synergistic effect when combined with meropenem and imipenem. Thus, the acetamide was able to optimize the effects of antibacterial drugs, reducing the concentrations necessary to cause bacterial death. These data indicate a potential future clinical use of these combinations, and further studies are needed to analyze this viability.